Stay updated on Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous revision v3.5.4 was removed from the visible history, updating the revision log.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry v3.5.4 was added to the record history. The previous revision v3.5.3 was removed, signaling an update to the page’s versioning.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now reflects a newer ClinicalTrials.gov software/UI revision label (v3.5.3 instead of v3.5.2), which represents an internal version update rather than a change to the trial’s recorded information.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded revision entry v3.4.3 and removed v3.4.2 from the history.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.